PUA Tri-Axis Dominant-Primary Series II-IV

Brassica nigra

Black Mustard

Tier IIPUA Tri-Axis Dominant-Primary Series

Target Trait

1.52×

fold-change

Sharp-dominant tri-axis U+A modulated fold-change

Technical Specifications

SKU

SS-F-M3-01334

Genomic Edits

GC Content

45.4%

Construct Length

5,060 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro cell-free

Host Strain

Cell-free

Receptor Target

TRPA1 + mGluR1 + Polyphenol-astringency axis

IFI Score

152

Pathway Edits

TRPA1 pathway primary gene cluster for sharp (IFI-P) tri-axis component
mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
Polyphenol-astringency axis pathway primary gene cluster for astringency (IFI-A) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent PUA pathway operation
Cross-pathway regulatory circuit for sharp-dominant PUA triple-axis expression
Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPA1, mGluR1, and Polyphenol-astringency axis pathways simultaneously engineeredSharp-dominant tri-axis expression strategy (PUA) with cross-pathway flux managementCell-free co-translation of multi-axis enzyme sets for in-vitro biochemical validation

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier II PUA triple-axis construct for advanced multi-modal sensory architecture combining sharp, umami, and astringency axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$699 · Tier II License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities